A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Clinical trial NCT05307705 · RECRUITING
Trial details
- NCT number
- NCT05307705
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-11
- Primary completion
- 2026-12-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.